首页> 外文期刊>Experimental and clinical transplantation >Hand Transplantation: Current Status and Immunologic Obstacles
【24h】

Hand Transplantation: Current Status and Immunologic Obstacles

机译:手移植:现状和免疫障碍

获取原文
           

摘要

Hand transplantation is the most common form of modern composite tissue allotransplantation, with 89 cases reported worldwide since 1998. The procedure is a treatment option for complex injuries that leave patients with structural, functional, and aesthetic deficits that cannot be addressed by other means. Successful application of this technology requires a multidisciplinary approach, incorporating not only skilled hand surgeons, transplant surgeons, and transplant immunologists, but also hand therapists, psychiatrists, medical specialists, anesthesiologists, and so on. Its long-term results depend on proper patient selection, a technically successful operation, postoperative rehabilitation, and an immunotherapy protocol that prevents rejection. Recent advances in transplant immunology are shifting the focus from immunosuppression to immunoregulation. Despite the enormous antigen load associated with composite tissue allografts, hand transplant has become a clinical reality, with immunosuppression comparable to that of solid-organ transplants. Our understanding of hand transplantation is still evolving, and ongoing research is needed to improve functional outcomes and to decrease the morbidity associated with long-term immunosup-pression. This review discusses the current protocols for upper extremity donation, transplant receipt, surgical techniques, postoperative rehabilitation and immuno-suppression, nerve regeneration, functional outcomes, ethical issues, and financial considerations.
机译:手移植是现代复合组织同种异体移植的最常见形式,自1998年以来,全世界报道了89例。该手术是一种复杂损伤的治疗选择,这种损伤使患者出现结构,功能和美学上的缺陷,无法通过其他方式解决。该技术的成功应用需要一种多学科的方法,不仅包括熟练的手外科医生,移植外科医生和移植免疫学家,而且还包括手治疗师,精神病医生,医学专家,麻醉师等。其长期结果取决于正确的患者选择,技术上成功的手术,术后康复以及防止排斥反应的免疫疗法方案。移植免疫学的最新进展正在将重点从免疫抑制转移到免疫调节。尽管与复合组织同种异体移植相关的抗原负荷巨大,但手移植已成为临床现实,其免疫抑制作用可与实体器官移植媲美。我们对手移植的理解仍在发展,需要进行持续的研究以改善功能结果并减少与长期免疫抑制相关的发病率。这篇综述讨论了有关上肢捐赠,移植收据,手术技术,术后康复和免疫抑制,神经再生,功能结局,道德问题和财务考虑因素的当前方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号